A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1
收藏DataCite Commons2026-04-03 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012960/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.
提供机构：
Vivli
创建时间：
2026-04-03
